A new continuous glucose monitor (CGM) that is not only non-invasive but that predicts blood sugar levels from ECG data ...

There are problems within the health system that mean full patient access to training on how to use the insulin pumps will ...

Not everyone in the health field is so bullish on the prospects of CGMs for everyone, and question whether digging in too ...

According to Professor Partha Kar, National Specialty Advisor, Diabetes, NHS England and co-lead of Diabetes GIRFT, NHS ...

More and more people are talking abut the monitoring device, also known as CGM, for non-diabetics. But not everyone in the health field is so bullish on the prospects of CGMs for everyone ...

Continuous Glucose Monitoring Devices Market to reach a value of US$ 12.51 Bn by 2031 at a CAGR of 9.9% between 2024 and 2031 BURLINGAME, CA, UNITED STATES, October 15, 2024 /EINPresswire / -- A ...

Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...

Continuous glucose monitoring (CGM) technologies have transformed diabetes management by providing real-time, accurate ...

The global continuous glucose monitoring systems (CGMS) market was valued at approximately USD 6,626.6 million in 2021 and is expected to grow to USD 31,708.2 million by 2032, with a CAGR of 17.0% ...

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

The Medicines and Healthcare products Regulatory Agency is urging people to report any safety concerns they have about ...

The CEO at the Illinois-based company with operations in Minnesota expects earning to return to a pre-pandemic profit model ...